Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Systemic Inflammatory Response Attenuating Cardiopulmonary Bypass Strategy Reduces New Ischemic/Embolic Lesions After Acute Type A Aortic Dissection Surgery: the sirA-CPB Randomized Clinical Trial

NCT07750548 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT07750548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07750548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Systemic Inflammatory Response Attenuating Cardiopulmonary Bypass Strategy Reduces New Ischemic/Embolic Lesions After Acute Type A Aortic Dissection Surgery: the sirA-CPB Randomized Clinical Trial
Lead sponsor
Xiangya Hospital of Central South University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 20, 2026
Completion date
June 30, 2030
Enrollment
270 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dissection, aortic